VALN — Valneva SE

—
Nasdaq · Health Care · Biotechnology · CIK 1836564 ·
Last close
$5.57
Market Cap
$527.69M
52W High
$12.18
52W Low
$4.75
ADV30
17,118
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 34,938,000 1,600,000 -26,172,000 -31,203,000 388,276,000 121,526,000 307,155,000
Mar 2026 30,903,000 4,723,000 -23,696,000 -32,073,000 372,013,000 105,265,000 295,314,000
Dec 2025 47,687,000 11,616,000 -27,685,000 -50,019,000 398,836,000 109,650,000 292,668,000
Sep 2025 29,409,000 5,503,000 -37,347,000 -44,355,000 448,229,000 143,462,000 297,752,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-55,691,000
Investing CF
$564,000
Financing CF
$14,569,000
CapEx
$-2,347,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.48
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-742,397,000
Inventory
$48,163,000
Receivables
$16,340,000
ST Investments
—
EBIT TTM
$-116,966,000
Pretax Income TTM
$-157,570,000
Interest Exp TTM
$40,604,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$142,938,000
EBITDA
$-98,721,000
Free Cash Flow
$-42,501,124
Enterprise Value
$720,229,248
Total Cash
$121,526,000
Total Debt
$210,231,008
Shares Out
94,823,458
Trailing EPS
$-2.09
Book Value
$0.99
ROE
-117.8%
ROA
-16.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 174,658,000 -81,631,000 -115,192,000 398,836,000 292,668,000 106,168,000 -52,894,000
Dec 2024 169,578,000 -77,769,000 -12,247,000 500,032,000 318,779,000 181,253,000 -67,218,000
Dec 2023 153,712,000 -82,112,000 -101,429,000 460,062,000 331,815,000 128,247,000 -202,744,000
Dec 2022 361,303,000 -113,443,000 -143,279,000 621,344,000 401,547,000 219,797,000 -245,343,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.19

Peers — same industry

TickerNameMarket CapLastDaily %
ETRA Electra Therapeutics, Inc. $524.10M $8.35 —
ENTX Entera Bio Ltd. $521.77M $3.00 —
SANA Sana Biotechnology, Inc. $563.31M $1.88 —
SRZN Surrozen, Inc./DE $571.47M $29.98 —
FENC FENNEC PHARMACEUTICALS INC. $479.44M $13.58 —

News headlines (Yahoo Finance, 1h cache)

Did Valneva's Fall Catch You Out? What Bears Saw
2026-11-13 20:08 · Yahoo
Valneva Reports Sustained 94% Seroresponse Five Years After a Single Dose of Chikungunya Vaccine IXCHIQ®
2026-11-10 06:00 · Yahoo
Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2
2026-11-09 06:00 · Yahoo
Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026
2026-11-04 16:45 · Yahoo
Declaration of shares and voting rights Status as of October 31, 2026
2026-11-03 17:00 · Yahoo
MHRA revokes approval for Valneva’s Ixchiq due to safety frailties
2026-10-21 10:08 · Yahoo
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
2026-10-14 15:45 · Yahoo
Valneva Shares Fall as UK Withdraws Approval for Ixchiq Chikungunya Vaccine
2026-10-08 10:09 · Yahoo
VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback
2026-10-07 21:09 · Yahoo
Valneva ADRs fall as UK revokes IXCHIQ marketing authorization
2026-10-07 20:39 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.